D-Wave Quantum Enters a Testing Fortnight with a $33.4 Million Backlog and an 81% Revenue Slide

D-Wave's revenue drops 81% but record $33.4M bookings spark credibility test at key investor events. Stock under pressure, analysts cautious.

D-Wave Quantum faces a stretch of high-profile investor events that will put its credibility to the test. Management must convince the market that a record order book can be converted into predictable revenue — something the first-quarter numbers conspicuously failed to show.

The earnings report landed with a jolt. Revenue plunged 81% to $2.86 million, down from $15 million in the same period last year. The net loss widened to $18.36 million, though the per-share loss of $0.05 came in narrower than the $0.08 analysts had penciled in. The headline figure that caught the eye, however, was the bookings number: a record $33.4 million, driven largely by a $20 million system sale to Florida Atlantic University and a $10 million two-year enterprise agreement.

That gap between orders and recognised revenue is what investors will press management on this week. The company is set to appear at J.P. Morgan’s Global Technology, Media and Communications Conference on May 20, followed by the Canaccord Genuity Virtual Quantum Symposium on May 21 and a TD Cowen event in New York on May 28. The first investor day on June 1 and the annual Qubits Europe user conference on June 18 in London round out a packed calendar.

The balance sheet, at least, buys time. Cash and marketable securities stood at $588.4 million at the end of March, a war chest that gives D-Wave room to operate while it tries to turn its order momentum into recurring revenue. Institutional investor Millennium Management has built a stake of roughly 2.27 million shares, signalling that some large funds are betting on the long-term strategy.

The stock, however, remains under pressure. In Frankfurt trading on Friday, shares closed at €17.48, down 7.29% on the day and 8.93% on the week. Year-to-date, the equity has lost 27.18%, though it still shows a 12-month gain of 77.22%. The technical picture is mixed: the RSI at 34.9 points to an oversold condition, while the price sits above its 50-day moving average of €15.68 but below the 200-day line near €20.01. In the US chart, the $20 zone is seen as key support, with a break above $22.22 potentially opening the path toward $31. An inverse head-and-shoulders pattern remains a talking point for technicians.

The broader quantum computing sector added to the gloom on Friday, with IonQ and Rigetti also suffering heavy losses. A fresh competitive benchmark is on the horizon: Honeywell has filed for an IPO of its majority-owned Quantinuum unit, a move that could draw new institutional interest into the sector while putting a well-funded rival squarely in the public spotlight.

Analyst reactions to the quarter were cautious but not dismissive. Mizuho cut its price target to $29 from $31 but maintained a positive stance. Canaccord lowered its target to $41 from $43, while Jefferies kept its Buy rating and $45 target unchanged.

What D-Wave needs to demonstrate in the weeks ahead is that the record $33.4 million in bookings is not just a one-off headline but the start of a reliable revenue engine. The first concrete test will come when management explains how the Florida Atlantic deal and the enterprise agreement translate into recognised sales. Until then, the stock is likely to remain a high-volatility play driven by expectations — and a long way from its annual peak.